Home Tools
Log in
Cart

Ras

Ras is a family of related proteins which is expressed in all animal cell lineages and organs. All Ras protein family members belong to a class of protein called small GTPase, and are involved in transmitting signals within cells (cellular signal transduction). Ras is the prototypical member of the Ras superfamily of proteins, which are all related in 3D structure and regulate diverse cell behaviours.
Signaling Pathways | Target | TargetMol
Cat. No. Product name CAS No. Purity Chemical Structure
T7764 CCG-222740 1922098-69-8 98.79%
CCG-222740
CCG-222740 is an inhibitor of Rho/MRTF pathway
T9972 Divarasib 2417987-45-0 98.79%
Divarasib
Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of < 0.01 μM. Divarasib irreversibly ...
T5469 K-Ras-IN-1 84783-01-7 98.72%
K-Ras-IN-1
K-Ras-IN-1 is a K-Ras inhibitor.
T9407 Rasarfin 674359-73-0 98.58%
Rasarfin
Rasarfin inhibits Ras and ARF6.
T22258 (S)-AMG-510 2252403-56-6 98.57%
(S)-AMG-510
(S)-AMG-510 is an S-type compound of AMG-510, a potent covalent inhibitor of KRAS G12C with potential antitumor activity.
T5379 (Rac)-Antineoplaston A10 77658-84-5 98.47%
(Rac)-Antineoplaston A10
(Rac)-Antineoplaston A10 (Antineoplaston A10) is a naturally occurring substance and the first antineoplaston in the human body to be chemically identified. It d...
T2267 BQU57 1637739-82-2 98.36%
BQU57
BQU57 shows selective inhibition for Ral relative to Ras or Rho and inhibit xenograft tumor growth.
T40286 KRAS G12C inhibitor 19 2649788-46-3 98.31%
KRAS G12C inhibitor 19
KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that shows anti-tumor activity in cellular assays, and the family inhibits tumor growth.
T3553 Y16 429653-73-6 98.26%
Y16
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated sign...
T2700 FTI-277 hydrochloride 180977-34-8 98.19%
FTI-277 hydrochloride
FTI-277 hydrochloride (FTI 277 HCl) is an effective and specific farnesyltransferase (FTase) inhibitor (IC50: 500 pM); this selectivity is about 100-fold than th...
T8473 MLS000532223 16616-39-0 98.11%
MLS000532223
MLS000532223 is a selectiveRho family GTPases inhibitor(EC50 : 16 μM to 120 μM).
T16021 MBQ-167 2097938-73-1 98.07%
MBQ-167
MBQ-167 is a dual inhibitor of Rac/Cdc42 (IC50s: 103 nM for Rac 1/2/3 and 78 nM for Cdc42 in MDA-MB-231 cells, respectively).
T7609 ARS-1620 1698055-85-4 98%
ARS-1620
ARS-1620 is a covalent inhibitor of K-RASG12C.
T1876 Kobe0065 436133-68-5 98%
Kobe0065
Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD; shows potent activity to competitively inhibit the binding of H...
T7131 Antineoplaston A10 91531-30-5 98%
Antineoplaston A10
Antineoplaston A10 (NSC-648539) is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer.
T22249 1588-A4 1698027-20-1 98%
1588-A4
1588-A4 (ARS-1620 Intermediate) is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.
T6302 Lonafarnib 193275-84-2 98%
Lonafarnib
Lonafarnib (Sch66336) is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B, and N-ras (IC50: 1.9/5.2/2.8 nM).
T7326 6H05 (TFA) 2061344-88-3 98%
6H05 (TFA)
6H05 TFA (6H05 trifluoroacetate) is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.
T7558 CID-1067700 314042-01-8 98%
CID-1067700
CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases(Rab7 with a Ki of 13 nM).
T5597 ZT-12-037-01 2328073-61-4 98%
ZT-12-037-01
Zt-12-037-01 is a ATP competitive STK19 inhibitor(IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N),respectively).
CCG-222740
T7764
CCG-222740 is an inhibitor of Rho/MRTF pathway
Divarasib
T9972
Divarasib (GDC-6036) (GDC-6036) is an investigational, oral, high-potency and selective KRAS G12C inhibitor with an IC50 of &lt; 0.01 μM. Divarasib irreversibly ...
K-Ras-IN-1
T5469
K-Ras-IN-1 is a K-Ras inhibitor.
Rasarfin
T9407
Rasarfin inhibits Ras and ARF6.
(S)-AMG-510
T22258
(S)-AMG-510 is an S-type compound of AMG-510, a potent covalent inhibitor of KRAS G12C with potential antitumor activity.
(Rac)-Antineoplaston A10
T5379
(Rac)-Antineoplaston A10 (Antineoplaston A10) is a naturally occurring substance and the first antineoplaston in the human body to be chemically identified. It d...
BQU57
T2267
BQU57 shows selective inhibition for Ral relative to Ras or Rho and inhibit xenograft tumor growth.
KRAS G12C inhibitor 19
T40286
KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that shows anti-tumor activity in cellular assays, and the family inhibits tumor growth.
Y16
T3553
Y16 is a G-protein–coupled Rho GEFs inhibitor; works synergistically with Rhosin/G04 in inhibiting LARG-RhoA interaction, RhoA activation, and RhoA-mediated sign...
FTI-277 hydrochloride
T2700
FTI-277 hydrochloride (FTI 277 HCl) is an effective and specific farnesyltransferase (FTase) inhibitor (IC50: 500 pM); this selectivity is about 100-fold than th...
MLS000532223
T8473
MLS000532223 is a selectiveRho family GTPases inhibitor(EC50 : 16 μM to 120 μM).
MBQ-167
T16021
MBQ-167 is a dual inhibitor of Rac/Cdc42 (IC50s: 103 nM for Rac 1/2/3 and 78 nM for Cdc42 in MDA-MB-231 cells, respectively).
ARS-1620
T7609
ARS-1620 is a covalent inhibitor of K-RASG12C.
Kobe0065
T1876
Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD; shows potent activity to competitively inhibit the binding of H...
Antineoplaston A10
T7131
Antineoplaston A10 (NSC-648539) is a Ras inhibitor potentially for the treatment of glioma, lymphoma, astrocytoma and breast cancer.
1588-A4
T22249
1588-A4 (ARS-1620 Intermediate) is an intermediate of ARS-1620 which is an atropisomeric selective KRASG12C inhibitor with desirable pharmacokinetics.
Lonafarnib
T6302
Lonafarnib (Sch66336) is an orally bioavailable FPTase inhibitor for H-ras, K-ras-4B, and N-ras (IC50: 1.9/5.2/2.8 nM).
6H05 (TFA)
T7326
6H05 TFA (6H05 trifluoroacetate) is a selective, and allosteric oncogenic mutant K-Ras(G12C) inhibitor.
CID-1067700
T7558
CID-1067700 is one of the first identified competitive inhibitors of nucleotide binding by Ras-related GTPases(Rab7 with a Ki of 13 nM).
ZT-12-037-01
T5597
Zt-12-037-01 is a ATP competitive STK19 inhibitor(IC50 values of 23.96 nM and 27.94 nM for STK19 (WT) and STK19 (D89N),respectively).
1 2 3 4 5 6
TargetMol